{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:35:23Z","timestamp":1792182923072,"version":"4.4.0"},"reference-count":176,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,11,28]],"date-time":"2019-11-28T00:00:00Z","timestamp":1574899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,11,28]],"date-time":"2019-11-28T00:00:00Z","timestamp":1574899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"EU Joint Programme \u2013 Neurodegenerative Disease Research through ZonMW","award":["733051067"],"award-info":[{"award-number":["733051067"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl. Stroke Res."],"published-print":{"date-parts":[[2020,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Stroke and Alzheimer\u2019s disease (AD) are cerebral pathologies with high socioeconomic impact that can occur together and mutually interact. Vascular factors predisposing to cerebrovascular disease have also been specifically associated with development of AD, and acute stroke is known to increase the risk to develop dementia.<\/jats:p><jats:p>Despite the apparent association, it remains unknown how acute cerebrovascular disease and development of AD are precisely linked and act on each other. It has been suggested that this interaction is strongly related to vascular deposition of amyloid-\u03b2 (A\u03b2), i.e., cerebral amyloid angiopathy (CAA). Furthermore, the blood\u2013brain barrier (BBB), perivascular space, and the glymphatic system, the latter proposedly responsible for the drainage of solutes from the brain parenchyma, may represent key pathophysiological pathways linking stroke, A\u03b2 deposition, and dementia.<\/jats:p><jats:p>In this review, we propose a hypothetic connection between CAA, stroke, perivascular space integrity, and dementia. Based on relevant pre-clinical research and a few clinical case reports, we speculate that impaired perivascular space integrity, inflammation, hypoxia, and BBB breakdown after stroke can lead to accelerated deposition of A\u03b2 within brain parenchyma and cerebral vessel walls or exacerbation of CAA. The deposition of A\u03b2 in the parenchyma would then be the initiating event leading to synaptic dysfunction, inducing cognitive decline and dementia. Maintaining the clearance of A\u03b2 after stroke could offer a new therapeutic approach to prevent post-stroke cognitive impairment and development into dementia.<\/jats:p>","DOI":"10.1007\/s12975-019-00755-2","type":"journal-article","created":{"date-parts":[[2019,11,28]],"date-time":"2019-11-28T00:17:52Z","timestamp":1574900272000},"page":"601-614","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":130,"title":["From Stroke to Dementia: a Comprehensive Review Exposing Tight Interactions Between Stroke and Amyloid-\u03b2 Formation"],"prefix":"10.1007","volume":"11","author":[{"given":"Romain","family":"Goulay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Mena Romo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elly M.","family":"Hol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4623-4078","authenticated-orcid":false,"given":"Rick M.","family":"Dijkhuizen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,28]]},"reference":[{"key":"755_CR1","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s11936-017-0542-6","volume":"19","author":"MB Bevers","year":"2017","unstructured":"Bevers MB, Kimberly WT. Critical care management of acute ischemic stroke. Curr Treat Options Cardiovasc Med. 2017;19:41.","journal-title":"Curr Treat Options Cardiovasc Med"},{"key":"755_CR2","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1080\/14737167.2017.1313118","volume":"17","author":"A Deb","year":"2017","unstructured":"Deb A, Thornton JD, Sambamoorthi U, Innes K. Direct and indirect cost of managing Alzheimer\u2019s disease and related dementias in the United States. Expert Rev Pharmacoecon Outcomes Res. 2017;17:189\u2013202.","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"755_CR3","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1212\/01.wnl.0000240129.46080.53","volume":"67","author":"C Regan","year":"2006","unstructured":"Regan C, Katona C, Walker Z, Hooper J, Donovan J, Livingston G. Relationship of vascular risk to the progression of Alzheimer disease. Neurology. 2006;67:1357\u201362.","journal-title":"Neurology."},{"key":"755_CR4","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1136\/jnnp-2011-301308","volume":"83","author":"A Charidimou","year":"2012","unstructured":"Charidimou A, Gang Q, Werring DJ. Sporadic cerebral amyloid angiopathy revisited: recent insights into pathophysiology and clinical spectrum. J Neurol Neurosurg Psychiatry. 2012;83:124\u201337.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"755_CR5","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1179\/016164103101202057","volume":"25","author":"RO Weller","year":"2003","unstructured":"Weller RO, Nicoll JA. Cerebral amyloid angiopathy: pathogenesis and effects on the ageing and Alzheimer brain. Neurol Res. 2003;25:611\u20136.","journal-title":"Neurol Res"},{"key":"755_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-008-0457-0","volume":"117","author":"RO Weller","year":"2009","unstructured":"Weller RO, Djuanda E, Yow HY, Carare RO. Lymphatic drainage of the brain and the pathophysiology of neurological disease. Acta Neuropathol (Berl). 2009;117:1\u201314.","journal-title":"Acta Neuropathol (Berl)"},{"key":"755_CR7","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1080\/14737175.2018.1480938","volume":"6","author":"SA Weber","year":"2018","unstructured":"Weber SA, Patel RK, Lutsep HL. Cerebral amyloid angiopathy: diagnosis and potential therapies. Expert Rev Neurother. 2018;6:503\u201313.","journal-title":"Expert Rev Neurother"},{"key":"755_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3988\/jcn.2011.7.1.1","volume":"7","author":"A Biffi","year":"2011","unstructured":"Biffi A, Greenberg SM. Cerebral amyloid angiopathy: a systematic review. J Clin Neurol. 2011;7:1\u20139.","journal-title":"J Clin Neurol"},{"key":"755_CR9","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1093\/brain\/awq321","volume":"134","author":"C Cordonnier","year":"2011","unstructured":"Cordonnier C, van der Flier WM. Brain microbleeds and Alzheimer\u2019s disease: innocent observation or key player? Brain. 2011;134:335\u201344.","journal-title":"Brain."},{"key":"755_CR10","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1212\/WNL.46.6.1592","volume":"46","author":"RJ Ellis","year":"1996","unstructured":"Ellis RJ, Olichney JM, Thal LJ, Mirra SS, Morris JC, Beekly D, et al. Cerebral amyloid angiopathy in the brains of patients with Alzheimer\u2019s disease: the CERAD experience, Part XV. Neurology. 1996;46:1592\u20136.","journal-title":"Neurology."},{"key":"755_CR11","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1212\/01.wnl.0000240285.89067.3f","volume":"67","author":"A Gamaldo","year":"2006","unstructured":"Gamaldo A, Moghekar A, Kilada S, Resnick SM, Zonderman AB, O\u2019Brien R. Effect of a clinical stroke on the risk of dementia in a prospective cohort. Neurology. 2006;67:1363\u20139.","journal-title":"Neurology."},{"key":"755_CR12","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1126\/science.1240514","volume":"340","author":"M Nedergaard","year":"2013","unstructured":"Nedergaard M. Neuroscience. Garbage truck of the brain. Science. 2013;340:1529\u201330.","journal-title":"Science."},{"key":"755_CR13","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature14432","volume":"523","author":"A Louveau","year":"2015","unstructured":"Louveau A, Smirnov I, Keyes TJ, Eccles JD, Rouhani SJ, Peske JD, et al. Structural and functional features of central nervous system lymphatic vessels. Nature. 2015;523:337\u201341.","journal-title":"Nature."},{"key":"755_CR14","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1002\/ana.24271","volume":"76","author":"BT Kress","year":"2014","unstructured":"Kress BT, Iliff JJ, Xia M, Wang M, Wei HS, Zeppenfeld D, et al. Impairment of paravascular clearance pathways in the aging brain. Ann Neurol. 2014;76:845\u201361.","journal-title":"Ann Neurol"},{"key":"755_CR15","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.nbd.2016.05.015","volume":"93","author":"W Peng","year":"2016","unstructured":"Peng W, Achariyar TM, Li B, Liao Y, Mestre H, Hitomi E, et al. Suppression of glymphatic fluid transport in a mouse model of Alzheimer\u2019s disease. Neurobiol Dis. 2016;93:215\u201325.","journal-title":"Neurobiol Dis"},{"key":"755_CR16","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/j.1750-3639.2008.00133.x","volume":"18","author":"RO Weller","year":"2008","unstructured":"Weller RO, Subash M, Preston SD, Mazanti I, Carare RO. Perivascular drainage of amyloid-beta peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer\u2019s disease. Brain Pathol. 2008;18:253\u201366.","journal-title":"Brain Pathol"},{"key":"755_CR17","doi-asserted-by":"publisher","first-page":"3092","DOI":"10.1161\/STROKEAHA.114.006617","volume":"45","author":"T Gaberel","year":"2014","unstructured":"Gaberel T, Gakuba C, Goulay R, Martinez De Lizarrondo S, Hanouz JL, Emery E, et al. Impaired glymphatic perfusion after strokes revealed by contrast-enhanced MRI: a new target for fibrinolysis? Stroke. 2014;45:3092\u20136.","journal-title":"Stroke"},{"key":"755_CR18","first-page":"419","volume":"13","author":"R Goulay","year":"2017","unstructured":"Goulay R, Flament J, Gauberti M, Naveau M, Pasquet N, Gakuba C, et al. Subarachnoid hemorrhage severely impairs brain parenchymal cerebrospinal fluid circulation in nonhuman primate. Outcome markers for clinical trials in cerebral amyloid angiopathy. Lancet Neurol. 2017;13:419\u201328.","journal-title":"Lancet Neurol"},{"key":"755_CR19","first-page":"1462","volume":"114","author":"R Borwn","year":"2018","unstructured":"Borwn R, Benvesniste H, Black SE, Charpak S, Dichgans M, Joutel A, et al. Understanding the role of the perivascular space in cerebral small vessel disease. Cerebrovasc Res. 2018;114:1462\u201373.","journal-title":"Cerebrovasc Res"},{"key":"755_CR20","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1111\/nan.12042","volume":"39","author":"RO Carare","year":"2013","unstructured":"Carare RO, Hawkes CA, Jeffrey M, Kalaria RN, Weller RO. Review: cerebral amyloid angiopathy, prion angiopathy, CADASIL and the spectrum of protein elimination failure angiopathies (PEFA) in neurodegenerative disease with a focus on therapy. Neuropathol Appl Neurobiol. 2013;39:593\u2013611.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"755_CR21","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3233\/JAD-2012-120658","volume":"32","author":"NU Barua","year":"2012","unstructured":"Barua NU, Miners JS, Bienemann AS, Wyatt MJ, Welser K, Tabor AB, et al. Convection-enhanced delivery of neprilysin: a novel amyloid-\u03b2-degrading therapeutic strategy. J Alzheimers Dis. 2012;32:43\u201356.","journal-title":"J Alzheimers Dis"},{"key":"755_CR22","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/S1474-4422(14)70097-3","volume":"13","author":"SM Greenberg","year":"2014","unstructured":"Greenberg SM, Al-Shahi Salma R, Biessels GJ, van Buchem M, Cordonnier C, Lee JM, et al. Developing biomarkers for cerebral amyloid angiopathy trials: do potential disease phenotypes hold promise?\u2014authors\u2019 reply. Lancet Neurol. 2014;13:540.","journal-title":"Lancet Neurol"},{"key":"755_CR23","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/nrn.2017.29","volume":"18","author":"UC M\u00fcller","year":"2017","unstructured":"M\u00fcller UC, Deller T, Korte M. Not just amyloid: physiological functions of the amyloid precursor protein family. Nat Rev Neurosci. 2017;18:281\u201398.","journal-title":"Nat Rev Neurosci"},{"key":"755_CR24","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/S0733-8619(05)70232-2","volume":"18","author":"DJ Selkoe","year":"2000","unstructured":"Selkoe DJ. The genetics and molecular pathology of Alzheimer\u2019s disease: roles of amyloid and the presenilins. Neurol Clin. 2000;18:903\u201322.","journal-title":"Neurol Clin"},{"key":"755_CR25","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1034\/j.1600-0463.2002.100509.x","volume":"110","author":"Z Wang","year":"2002","unstructured":"Wang Z, Wu D, Vinters HV. Hypoxia and reoxygenation of brain microvascular smooth muscle cells in vitro: cellular responses and expression of cerebral amyloid angiopathy-associated proteins. APMIS Acta Pathol Microbiol Immunol Scand. 2002;110:423\u201334.","journal-title":"APMIS Acta Pathol Microbiol Immunol Scand"},{"key":"755_CR26","doi-asserted-by":"publisher","first-page":"11172","DOI":"10.1073\/pnas.0603838103","volume":"103","author":"L Rajendran","year":"2006","unstructured":"Rajendran L, Honsho M, Zahn TR, Keller P, Geiger KD, Verkade P, et al. Alzheimer\u2019s disease beta-amyloid peptides are released in association with exosomes. Proc Natl Acad Sci U S A. 2006;103:11172\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"755_CR27","doi-asserted-by":"publisher","first-page":"e82321","DOI":"10.1371\/journal.pone.0082321","volume":"8","author":"N Hasebe","year":"2013","unstructured":"Hasebe N, Fujita Y, Ueno M, Yoshimura K, Fujino Y, Yamashita T. Soluble \u03b2-amyloid precursor protein alpha binds to p75 neurotrophin receptor to promote neurite outgrowth. PLoS One. 2013;8:e82321.","journal-title":"PLoS One"},{"key":"755_CR28","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.cell.2015.12.056","volume":"164","author":"B De Strooper","year":"2016","unstructured":"De Strooper B, Karran E. The cellular phase of Alzheimer\u2019s disease. Cell. 2016;164:603\u201315.","journal-title":"Cell."},{"key":"755_CR29","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/alzrt258","volume":"6","author":"MP Kummer","year":"2014","unstructured":"Kummer MP, Heneka MT. Truncated and modified amyloid-beta species. Alzheimers Res Ther. 2014;6:28.","journal-title":"Alzheimers Res Ther"},{"key":"755_CR30","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.neurobiolaging.2004.08.002","volume":"26","author":"M Duering","year":"2005","unstructured":"Duering M, Grimm MOW, Grimm HS, Schr\u00f6de J, Hartmann T. Mean age of onset in familial Alzheimer\u2019s disease is determined by amyloid beta 42. Neurobiol Aging. 2005;26:785\u20138.","journal-title":"Neurobiol Aging"},{"key":"755_CR31","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.brainres.2007.01.070","volume":"1142","author":"PM Clifford","year":"2007","unstructured":"Clifford PM, Zarrabi S, Siu G, Kinsler KJ, Kosciuk MC, Venkataraman V, et al. Abeta peptides can enter the brain through a defective blood-brain barrier and bind selectively to neurons. Brain Res. 2007;1142:223\u201336.","journal-title":"Brain Res"},{"key":"755_CR32","doi-asserted-by":"publisher","unstructured":"Czeczor JK, McGee SL. Emerging roles for the amyloid precursor protein and derived peptides in the regulation of cellular and systemic metabolism. J Neuroendocrinol. 2017. https:\/\/doi.org\/10.1111\/jne.12470.","DOI":"10.1111\/jne.12470"},{"key":"755_CR33","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.ejphar.2004.02.049","volume":"490","author":"S Hoyer","year":"2004","unstructured":"Hoyer S. Glucose metabolism and insulin receptor signal transduction in Alzheimer disease. Eur J Pharmacol. 2004;490:115\u201325.","journal-title":"Eur J Pharmacol"},{"key":"755_CR34","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1159\/000213592","volume":"40","author":"W Meier-Ruge","year":"1994","unstructured":"Meier-Ruge W, Bertoni-Freddari C, Iwangoff P. Changes in brain glucose metabolism as a key to the pathogenesis of Alzheimer\u2019s disease. Gerontology. 1994;40:246\u201352.","journal-title":"Gerontology."},{"key":"755_CR35","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1523\/JNEUROSCI.17-03-01046.1997","volume":"17","author":"RJ Mark","year":"1997","unstructured":"Mark RJ, Pang Z, Geddes JW, Uchida K, Mattson MP. Amyloid beta-peptide impairs glucose transport in hippocampal and cortical neurons: involvement of membrane lipid peroxidation. J Neurosci. 1997;17:1046\u201354.","journal-title":"J Neurosci"},{"key":"755_CR36","doi-asserted-by":"publisher","first-page":"e15230","DOI":"10.1371\/journal.pone.0015230","volume":"5","author":"LM Saraiva","year":"2010","unstructured":"Saraiva LM, Seixas da Silva GS, Galina A, da Silva WS, Klein WL, Ferreira ST, et al. Amyloid-\u03b2 triggers the release of neuronal hexokinase 1 from mitochondria. PLoS One. 2010;5:e15230.","journal-title":"PLoS One"},{"key":"755_CR37","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/0197-0186(94)00100-9","volume":"26","author":"M Bigl","year":"1995","unstructured":"Bigl M, Eschrich K. Interaction of rat brain phosphofructokinase with Alzheimer\u2019s beta A4-amyloid. Neurochem Int. 1995;26:69\u201375.","journal-title":"Neurochem Int"},{"key":"755_CR38","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1096\/fj.05-4195fje","volume":"19","author":"RC Cumming","year":"2005","unstructured":"Cumming RC, Schubert D. Amyloid-beta induces disulfide bonding and aggregation of GAPDH in Alzheimer\u2019s disease. FASEB J. 2005;19:2060\u20132.","journal-title":"FASEB J"},{"key":"755_CR39","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1038\/ncb1313","volume":"7","author":"MOW Grimm","year":"2005","unstructured":"Grimm MOW, Grimm HS, P\u00e4tzold AJ, Zinser EG, Halonen R, Duering M, et al. Regulation of cholesterol and sphingomyelin metabolism by amyloid-beta and presenilin. Nat Cell Biol. 2005;7:1118\u201323.","journal-title":"Nat Cell Biol"},{"key":"755_CR40","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/nrendo.2016.169","volume":"13","author":"PJ Meikle","year":"2017","unstructured":"Meikle PJ, Summers SA. Sphingolipids and phospholipids in insulin resistance and related metabolic disorders. Nat Rev Endocrinol. 2017;13:79\u201391.","journal-title":"Nat Rev Endocrinol"},{"key":"755_CR41","doi-asserted-by":"publisher","first-page":"RC221","DOI":"10.1523\/JNEUROSCI.22-10-j0001.2002","volume":"22","author":"L Xie","year":"2002","unstructured":"Xie L, Helmerhorst E, Taddei K, Plewright B, Van Bronswijk W, Martins R. Alzheimer\u2019s beta-amyloid peptides compete for insulin binding to the insulin receptor. J Neurosci. 2002;22:RC221.","journal-title":"J Neurosci"},{"key":"755_CR42","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/380168a0","volume":"380","author":"T Thomas","year":"1996","unstructured":"Thomas T, Thomas G, McLendon C, Sutton T, Mullan M. Beta-amyloid-mediated vasoactivity and vascular endothelial damage. Nature. 1996;380:168\u201371.","journal-title":"Nature"},{"key":"755_CR43","doi-asserted-by":"publisher","first-page":"7655","DOI":"10.1523\/JNEUROSCI.17-20-07655.1997","volume":"17","author":"F Zhang","year":"1997","unstructured":"Zhang F, Eckman C, Younkin S, Hsiao KK, Iadecola C. Increased susceptibility to ischemic brain damage in transgenic mice overexpressing the amyloid precursor protein. J Neurosci. 1997;17:7655\u201361.","journal-title":"J Neurosci"},{"key":"755_CR44","doi-asserted-by":"publisher","first-page":"9735","DOI":"10.1073\/pnas.97.17.9735","volume":"97","author":"K Niwa","year":"2000","unstructured":"Niwa K, Younkin L, Ebeling C, Turner SK, Westaway D, Younkin S, et al. Abeta 1-40-related reduction in functional hyperemia in mouse neocortex during somatosensory activation. Proc Natl Acad Sci U S A. 2000;97:9735\u201340.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"755_CR45","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1126\/science.1072994","volume":"297","author":"J Hardy","year":"2002","unstructured":"Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics. Science. 2002;297:353\u20136.","journal-title":"Science."},{"key":"755_CR46","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1126\/science.1197623","volume":"330","author":"KG Mawuenyega","year":"2010","unstructured":"Mawuenyega KG, Sigurdson W, Ovod V, Munsell L, Kasten T, Morris JC, et al. Decreased clearance of CNS beta-amyloid in Alzheimer\u2019s disease. Science. 2010;330:1774.","journal-title":"Science."},{"key":"755_CR47","first-page":"1","volume":"11","author":"H Benveniste","year":"2018","unstructured":"Benveniste H, Liu X, Koundal S, Sanggaard S, Lee H, Wardlaw J. The glymphatic system and waste clearance with brain aging: a review. Gerontology. 2018;11:1\u201314.","journal-title":"Gerontology."},{"key":"755_CR48","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/nm0896-864","volume":"2","author":"D Scheuner","year":"1996","unstructured":"Scheuner D, Eckman C, Jensen M, Song X, Citron M, Suzuki N, et al. Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer\u2019s disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer\u2019s disease. Nat Med. 1996;2:864\u201370.","journal-title":"Nat Med"},{"key":"755_CR49","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1111\/bpa.12159","volume":"24","author":"CA Hawkes","year":"2014","unstructured":"Hawkes CA, Jayakody N, Johnston DA, Bechmann I, Carare RO. Failure of perivascular drainage of \u03b2-amyloid in cerebral amyloid angiopathy. Brain Pathol. 2014;24:396\u2013403.","journal-title":"Brain Pathol"},{"key":"755_CR50","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nrneurol.2015.119","volume":"11","author":"JM Tarasoff-Conway","year":"2015","unstructured":"Tarasoff-Conway JM, Carare RO, Osorio RS, Glodzik L, Butler T, Fieremans E, et al. Clearance systems in the brain\u2014implications for Alzheimer disease. Nat Rev Neurol. 2015;11:457\u201370.","journal-title":"Nat Rev Neurol"},{"key":"755_CR51","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1172\/JCI10498","volume":"106","author":"M Shibata","year":"2000","unstructured":"Shibata M, Yamada S, Kumar SR, Calero M, Bading J, Frangione B, et al. Clearance of Alzheimer\u2019s amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. J Clin Invest. 2000;106:1489\u201399.","journal-title":"J Clin Invest"},{"key":"755_CR52","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1124\/pr.57.2.4","volume":"57","author":"BT Hawkins","year":"2005","unstructured":"Hawkins BT, Davis TP. The blood-brain barrier\/neurovascular unit in health and disease. Pharmacol Rev. 2005;57:173\u201385.","journal-title":"Pharmacol Rev"},{"key":"755_CR53","doi-asserted-by":"publisher","first-page":"136","DOI":"10.3389\/fnagi.2015.00136","volume":"7","author":"A Ramanathan","year":"2015","unstructured":"Ramanathan A, Nelson AR, Sagare AP, Zlokovic BV. Impaired vascular-mediated clearance of brain amyloid beta in Alzheimer\u2019s disease: the role, regulation and restoration of LRP1. Front Aging Neurosci. 2015;7:136.","journal-title":"Front Aging Neurosci"},{"key":"755_CR54","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/nrn3114","volume":"12","author":"BV Zlokovic","year":"2011","unstructured":"Zlokovic BV. Neurovascular pathways to neurodegeneration in Alzheimer\u2019s disease and other disorders. Nat Rev Neurosci. 2011;12:723\u201338.","journal-title":"Nat Rev Neurosci"},{"key":"755_CR55","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3389\/fnagi.2014.00093","volume":"6","author":"T Kanekiyo","year":"2014","unstructured":"Kanekiyo T, Bu G. The low-density lipoprotein receptor-related protein 1 and amyloid-\u03b2 clearance in Alzheimer\u2019s disease. Front Aging Neurosci. 2014;6:93.","journal-title":"Front Aging Neurosci"},{"key":"755_CR56","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1111\/j.1471-4159.2010.07002.x","volume":"115","author":"BV Zlokovic","year":"2010","unstructured":"Zlokovic BV, Deane R, Sagare AP, Bell RD, Winkler EA. Low-density lipoprotein receptor-related protein-1: a serial clearance homeostatic mechanism controlling Alzheimer\u2019s amyloid \u03b2-peptide elimination from the brain. J Neurochem. 2010;115:1077\u201389.","journal-title":"J Neurochem"},{"key":"755_CR57","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1007\/s11095-006-0208-7","volume":"23","author":"C Tamaki","year":"2006","unstructured":"Tamaki C, Ohtsuki S, Iwatsubo T, Hashimoto T, Yamada K, Yabuki C, et al. Major involvement of low-density lipoprotein receptor-related protein 1 in the clearance of plasma free amyloid beta-peptide by the liver. Pharm Res. 2006;23:1407\u201316.","journal-title":"Pharm Res"},{"key":"755_CR58","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1038\/nm1635","volume":"13","author":"A Sagare","year":"2007","unstructured":"Sagare A, Deane R, Bell RD, Johnson B, Hamm K, Pendu R, et al. Clearance of amyloid-beta by circulating lipoprotein receptors. Nat Med. 2007;13:1029\u201331.","journal-title":"Nat Med"},{"key":"755_CR59","doi-asserted-by":"publisher","first-page":"3285","DOI":"10.1172\/JCI25247","volume":"115","author":"JR Cirrito","year":"2005","unstructured":"Cirrito JR, Deane R, Fagan AM, Spinner ML, Parsadanian M, Finn MB, et al. P-glycoprotein deficiency at the blood-brain barrier increases amyloid-beta deposition in an Alzheimer disease mouse model. J Clin Invest. 2005;115:3285\u201390.","journal-title":"J Clin Invest"},{"key":"755_CR60","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.nurt.2008.05.011","volume":"5","author":"BV Zlokovic","year":"2008","unstructured":"Zlokovic BV. New therapeutic targets in the neurovascular pathway in Alzheimer\u2019s disease. Neurotherapeutics. 2008;5:409\u201314.","journal-title":"Neurotherapeutics."},{"key":"755_CR61","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/nm890","volume":"9","author":"R Deane","year":"2003","unstructured":"Deane R, Du Yan S, Submamaryan RK, LaRue B, Jovanovic S, Hogg E, et al. RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain. Nat Med. 2003;9:907\u201313.","journal-title":"Nat Med"},{"key":"755_CR62","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.4049\/jimmunol.1101121","volume":"188","author":"S Liu","year":"2012","unstructured":"Liu S, Liu Y, Hao W, Wolf L, Kiliaan AJ, Penke B, et al. TLR2 is a primary receptor for Alzheimer\u2019s amyloid \u03b2 peptide to trigger neuroinflammatory activation. J Immunol. 2012;188:1098\u2013107.","journal-title":"J Immunol"},{"key":"755_CR63","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s00401-006-0115-3","volume":"112","author":"JE Donahue","year":"2006","unstructured":"Donahue JE, Flaherty SL, Johanson CE, Duncan JA, Silverberg GD, Miller MC, et al. RAGE, LRP-1, and amyloid-beta protein in Alzheimer\u2019s disease. Acta Neuropathol. 2006;112:405\u201315.","journal-title":"Acta Neuropathol"},{"key":"755_CR64","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1093\/brain\/awu046","volume":"137","author":"M Shinohara","year":"2014","unstructured":"Shinohara M, Fujioka S, Murray ME, Wojtas A, Baker M, Rovelet-Lecrux A, et al. Regional distribution of synaptic markers and APP correlate with distinct clinicopathological features in sporadic and familial Alzheimer\u2019s disease. Brain. 2014;137:1533\u201349.","journal-title":"Brain."},{"key":"755_CR65","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.neuint.2003.11.006","volume":"45","author":"NJ Abbott","year":"2004","unstructured":"Abbott NJ. Evidence for bulk flow of brain interstitial fluid: significance for physiology and pathology. Neurochem Int. 2004;45:545\u201352.","journal-title":"Neurochem Int"},{"key":"755_CR66","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/j.1365-2990.2007.00926.x","volume":"34","author":"RO Carare","year":"2008","unstructured":"Carare RO, Bernardes-Silva M, Newman TA, Page AM, Nicoll JR, Perry VH, et al. Solutes, but not cells, drain from the brain parenchyma along basement membranes of capillaries and arteries: significance for cerebral amyloid angiopathy and neuroimmunology. Neuropathol Appl Neurobiol. 2008;34:131\u201344.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"755_CR67","first-page":"F835","volume":"246","author":"I Szentistv\u00e1nyi","year":"1984","unstructured":"Szentistv\u00e1nyi I, Patlak CS, Ellis RA, Cserr HF. Drainage of interstitial fluid from different regions of rat brain. Am J Phys. 1984;246:F835\u201344.","journal-title":"Am J Phys"},{"key":"755_CR68","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1148\/radiology.217.3.r00dc42877","volume":"217","author":"NJ Alperin","year":"2000","unstructured":"Alperin NJ, Lee SH, Loth F, Raksin PB, Lichtor T. MR-intracranial pressure (ICP): a method to measure intracranial elastance and pressure noninvasively by means of MR imaging: baboon and human study. Radiology. 2000;217:877\u201385.","journal-title":"Radiology."},{"key":"755_CR69","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/j.1750-3639.1992.tb00704.x","volume":"2","author":"RO Weller","year":"1992","unstructured":"Weller RO, Kida S, Zhang ET. Pathways of fluid drainage from the brain\u2014morphological aspects and immunological significance in rat and man. Brain Pathol. 1992;2:277\u201384.","journal-title":"Brain Pathol"},{"key":"755_CR70","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1743-8454-7-9","volume":"7","author":"M Pollay","year":"2010","unstructured":"Pollay M. The function and structure of the cerebrospinal fluid outflow system. Cerebrospinal Fluid Res. 2010;7:9.","journal-title":"Cerebrospinal Fluid Res"},{"key":"755_CR71","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1084\/jem.20142290","volume":"212","author":"A Aspelund","year":"2015","unstructured":"Aspelund A, Antila S, Proulx ST, Karlsen TV, Karaman S, Detmar M, et al. A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules. J Exp Med. 2015;212:991\u20139.","journal-title":"J Exp Med"},{"key":"755_CR72","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3389\/fnana.2017.00101","volume":"11","author":"A Bacyinski","year":"2017","unstructured":"Bacyinski A, Xu M, Wang W, Hu J. The paravascular pathway for brain waste clearance: current understanding, significance and controversy. Front Neuroanat. 2017;11:101.","journal-title":"Front Neuroanat"},{"key":"755_CR73","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.1007\/s11064-015-1581-6","volume":"40","author":"NA Jessen","year":"2015","unstructured":"Jessen NA, Munk ASF, Lundgaard I, Nedergaard M. The glymphatic system: a beginner\u2019s guide. Neurochem Res. 2015;40:2583\u201399.","journal-title":"Neurochem Res"},{"key":"755_CR74","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1007\/s00259-017-3814-1","volume":"45","author":"N Ezawa","year":"2018","unstructured":"Ezawa N, Katoh N, Oguchi K, Yoshinaga T, Yazaki M, Sekijima Y. Vizualization of multiple organ amyloid involvement in systemic amyloidosis using 11C-PiB PET imaging. Eur J Nucl Med Mol Imaging. 2018;45:452\u201361.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"755_CR75","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13550-014-0037-3","volume":"4","author":"A Snellman","year":"2012","unstructured":"Snellman A, Rokka J, L\u00f3pez-Pic\u00f3n FR, Eskola O, Salmona M, Forloni G, et al. In vivo PET imaging of beta-amyloid deposition in mouse models of Alzheimer\u2019s disease with a high specific activity PET imaging agent [(18)F]flutemetamol. EJNMMI Res. 2012;4:37.","journal-title":"EJNMMI Res"},{"key":"755_CR76","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1042\/CS20170004","volume":"131","author":"F Held","year":"2017","unstructured":"Held F, Morris AWJ, Pirici D, Niklass S, Sharp MMG, Garz C, et al. Vascular basement membrane alterations and \u03b2-amyloid accumulations in an animal model of cerebral small vessel disease. Clin Sci (Lond). 2017;131:1001\u201313.","journal-title":"Clin Sci (Lond)"},{"key":"755_CR77","doi-asserted-by":"publisher","first-page":"15078","DOI":"10.1074\/jbc.M114.610931","volume":"290","author":"M Hernandez-Guillamon","year":"2015","unstructured":"Hernandez-Guillamon M, Mawhirt S, Blais S, Montaner J, Neubert TA, Rostagno A, et al. Sequential amyloid-\u03b2 degradation by the matrix metalloproteases MMP-2 and MMP-9. J Biol Chem. 2015;290:15078\u201391.","journal-title":"J Biol Chem"},{"key":"755_CR78","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/S0896-6273(03)00787-6","volume":"40","author":"MA Leissring","year":"2003","unstructured":"Leissring MA, Farris W, Chang AY, Walsh DM, Wu X, Sun X, et al. Enhanced proteolysis of beta-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death. Neuron. 2003;40:1087\u201393.","journal-title":"Neuron."},{"key":"755_CR79","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1097\/01.jnen.0000240463.87886.9a","volume":"65","author":"JS Miners","year":"2006","unstructured":"Miners JS, Van Helmond Z, Chalmers K, Wilcock G, Love S, Kehoe PG. Decreased expression and activity of neprilysin in Alzheimer disease are associated with cerebral amyloid angiopathy. J Neuropathol Exp Neurol. 2006;65:1012\u201321.","journal-title":"J Neuropathol Exp Neurol"},{"key":"755_CR80","doi-asserted-by":"publisher","first-page":"241","DOI":"10.2353\/ajpath.2007.070105","volume":"171","author":"W Farris","year":"2007","unstructured":"Farris W, Sch\u00fctz SG, Cirrito JR, Shankar GM, Sun X, George A, et al. Loss of neprilysin function promotes amyloid plaque formation and causes cerebral amyloid angiopathy. Am J Pathol. 2007;171:241\u201351.","journal-title":"Am J Pathol"},{"key":"755_CR81","first-page":"a006379","volume":"2","author":"T Saido","year":"2012","unstructured":"Saido T, Leissring MA. Proteolytic degradation of amyloid \u03b2-protein. Cold Spring Harb Perpect Med. 2012;2:a006379.","journal-title":"Cold Spring Harb Perpect Med"},{"key":"755_CR82","doi-asserted-by":"publisher","first-page":"4023","DOI":"10.1523\/JNEUROSCI.3442-16.2017","volume":"37","author":"CC Liu","year":"2017","unstructured":"Liu CC, Hu J, Zhao N, Wang J, Na W, Cirrito JR, et al. Astrocytic LRP1 mediates brain A\u03b2 clearance and impacts amyloid deposition. J Neurosci. 2017;37:4023\u201331.","journal-title":"J Neurosci"},{"key":"755_CR83","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/j.1749-6632.2000.tb06367.x","volume":"903","author":"R Prior","year":"2000","unstructured":"Prior R, Wihl G, Urmoneit B. Apolipoprotein E, smooth muscle cells and the pathogenesis of cerebral amyloid angiopathy: the potential role of impaired cerebrovascular A beta clearance. Ann N Y Acad Sci. 2000;903:180\u20136.","journal-title":"Ann N Y Acad Sci"},{"key":"755_CR84","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.celrep.2013.08.042","volume":"5","author":"P Nilsson","year":"2013","unstructured":"Nilsson P, Loganathan K, Sekiguchi M, Matsuba Y, Hui K, Tsubuki S, et al. A\u03b2 secretion and plaque formation depend on autophagy. Cell Rep. 2013;5:61\u20139.","journal-title":"Cell Rep"},{"key":"755_CR85","doi-asserted-by":"publisher","first-page":"147ra111","DOI":"10.1126\/scitranslmed.3003748","volume":"4","author":"JJ Iliff","year":"2012","unstructured":"Iliff JJ, Wang M, Liao Y, Plogg BA, Peng W, Gundersen GA, et al. A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid \u03b2. Sci Transl Med. 2012;4:147ra111.","journal-title":"Sci Transl Med"},{"key":"755_CR86","doi-asserted-by":"publisher","first-page":"18190","DOI":"10.1523\/JNEUROSCI.1592-13.2013","volume":"46","author":"JJ Iliff","year":"2013","unstructured":"Iliff JJ, Wang M, Zeppenfeld DM, Venkataraman A, Plog BA, Liao Y, et al. Cerebral arterial pulsation drives paravascular CSF-interstitial fluid exchange in the murine brain. J Neurosci. 2013;46:18190\u20139.","journal-title":"J Neurosci"},{"key":"755_CR87","doi-asserted-by":"crossref","first-page":"205846011560963","DOI":"10.1177\/2058460115609635","volume":"4","author":"PK Eide","year":"2015","unstructured":"Eide PK, Ringstad G. MRI with intrathecal MRI gadolinium contrast medium administration: a possible method to assess glymphatic function in human brain. Acta Radiol Open. 2015;4:2058460115609635.","journal-title":"Acta Radiol Open"},{"key":"755_CR88","doi-asserted-by":"publisher","unstructured":"Ringstad G, Valnes LM, Dale AM, Pripp AH, Vatnehol SS, Emblem KE, et al. Brain-wide glymphatic enhancement and clearance in humans assessed with MRI. JCI Insight. 2018. https:\/\/doi.org\/10.1172\/jci.insight.121537.","DOI":"10.1172\/jci.insight.121537"},{"key":"755_CR89","doi-asserted-by":"publisher","first-page":"4299","DOI":"10.1007\/s00018-016-2348-1","volume":"73","author":"P Wostyn","year":"2016","unstructured":"Wostyn P, De Groot V, Van Dam D, Audenaert K, Killer HE, De Deyn PP. Age-related macular degeneration, glaucoma and Alzheimer\u2019s disease: amyloidogenic diseases with the same glymphatic background? Cell Mol Life Sci. 2016;73:4299\u2013301.","journal-title":"Cell Mol Life Sci"},{"key":"755_CR90","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1177\/0271678X16661202","volume":"37","author":"I Lundgaard","year":"2017","unstructured":"Lundgaard I, Lu ML, Yang E, Peng W, Mestre H, Hitomi E, et al. Glymphatic clearance controls state-dependent changes in brain lactate concentration. J Cereb Blood Flow Metab. 2017;37:2112\u201324.","journal-title":"J Cereb Blood Flow Metab"},{"key":"755_CR91","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13024-016-0138-8","volume":"11","author":"TM Achariyar","year":"2016","unstructured":"Achariyar TM, Li B, Peng W, Verghese PB, Shi Y, McConnell E, et al. Glymphatic distribution of CSF-derived apoE into brain is isoform specific and suppressed during sleep deprivation. Mol Neurodegener. 2016;11:74.","journal-title":"Mol Neurodegener"},{"key":"755_CR92","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1089\/rej.2013.1530","volume":"16","author":"AR Mendelsohn","year":"2013","unstructured":"Mendelsohn AR, Larrick JW. Sleep facilitates clearance of metabolites from the brain: glymphatic function in aging and neurodegenerative diseases. Rejuvenation Res. 2013;16:518\u201323.","journal-title":"Rejuvenation Res"},{"key":"755_CR93","doi-asserted-by":"publisher","first-page":"710","DOI":"10.7150\/thno.19154","volume":"8","author":"C Gakuba","year":"2018","unstructured":"Gakuba C, Gaberel T, Goursaud S, Bourges J, Di Palma C, Quenault A, et al. General anesthesia inhibits the activity of the \u201cglymphatic system\u201d. Theranostics. 2018;8:710\u201322.","journal-title":"Theranostics."},{"key":"755_CR94","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1126\/science.1241224","volume":"342","author":"L Xie","year":"2013","unstructured":"Xie L, Kang H, Xu Q, Chen MJ, Liao Y, Thiyagarajan M, et al. Sleep drives metabolite clearance from the adult brain. Science. 2013;342:373\u20137.","journal-title":"Science."},{"key":"755_CR95","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.nbscr.2016.08.002","volume":"2","author":"J Holth","year":"2017","unstructured":"Holth J, Patel T, Holtzman DM. Sleep in Alzheimer\u2019s disease\u2014beyond amyloid. Neurobiol Sleep Circadian Rhythms. 2017;2:4\u201314.","journal-title":"Neurobiol Sleep Circadian Rhythms"},{"key":"755_CR96","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1212\/WNL.0000000000003902","volume":"88","author":"C Ma","year":"2017","unstructured":"Ma C, Pavlova M, Liu Y, Liu Y, Huangfu C, Wu S, et al. Probable REM sleep behavior disorder and risk of stroke: a prospective study. Neurology. 2017;88:1849\u201355.","journal-title":"Neurology."},{"key":"755_CR97","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1097\/PHM.0000000000000744","volume":"96","author":"KL Joa","year":"2017","unstructured":"Joa KL, Kim WH, Choi HY, Park CH, Kim ES, Lee SJ, et al. The effect of sleep disturbances on the functional recovery of rehabilitation inpatients following mild and moderate stroke. Am J Phys Med Rehabil. 2017;96:743\u20130.","journal-title":"Am J Phys Med Rehabil"},{"key":"755_CR98","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.neurobiolaging.2017.01.011","volume":"53","author":"A Gabelle","year":"2017","unstructured":"Gabelle A, Jaussent I, Hirtz C, Vialaret J, Navucet S, Grasselli C, et al. Cerebrospinal fluid levels of orexin-A and histamine, and sleep profile within the Alzheimer process. Neurobiol Aging. 2017;53:59\u201366.","journal-title":"Neurobiol Aging"},{"key":"755_CR99","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1093\/brain\/awx003","volume":"140","author":"G Banerjee","year":"2017","unstructured":"Banerjee G, Kim HJ, Fox Z, J\u00e4ger HR, Wilson D, Charidimou A, et al. MRI-visible perivascular space location is associated with Alzheimer\u2019s disease independently of amyloid burden. Brain. 2017;140:1107\u201316.","journal-title":"Brain."},{"key":"755_CR100","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1177\/0271678X15620434","volume":"36","author":"SJ van Veluw","year":"2016","unstructured":"van Veluw SJ, Biessels GJ, Bouvy WH, Spliet WG, Zwanenburg JJ, Luijten PR, et al. Cerebral amyloid angiopathy severity is linked to dilation of juxtacortical perivascular spaces. J Cereb Blood Flow Metab. 2016;36:576\u201380.","journal-title":"J Cereb Blood Flow Metab"},{"key":"755_CR101","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.sleep.2016.12.012","volume":"32","author":"Q He","year":"2017","unstructured":"He Q, Sun H, Wu X, Zhang P, Dai H, Ai C, et al. Sleep duration and risk of stroke: a dose-response meta-analysis of prospective cohort studies. Sleep Med. 2017;32:66\u201374.","journal-title":"Sleep Med"},{"key":"755_CR102","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1093\/brain\/awx047","volume":"140","author":"A Charidimou","year":"2012","unstructured":"Charidimou A, Boulouis G, Gurol ME, Ayata C, Bacskai BJ, Frosch MP, et al. Emerging concepts in sporadic cerebral amyloid angiopathy. Brain. 2012;140:1829\u201350.","journal-title":"Brain."},{"key":"755_CR103","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/j.1750-3639.2006.tb00560.x","volume":"16","author":"MC Herzig","year":"2006","unstructured":"Herzig MC, Van Nostrand WE, Jucker M. Mechanism of cerebral beta-amyloid angiopathy: murine and cellular models. Brain Pathol. 2006;16:40\u201354.","journal-title":"Brain Pathol"},{"key":"755_CR104","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s11883-012-0254-z","volume":"14","author":"E Auriel","year":"2012","unstructured":"Auriel E, Greenberg SM. The pathophysiology and clinical presentation of cerebral amyloid angiopathy. Curr Atheroscler Rep. 2012;14:343\u201350.","journal-title":"Curr Atheroscler Rep"},{"key":"755_CR105","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1111\/j.1749-6632.2000.tb06381.x","volume":"903","author":"P Burgermeister","year":"2000","unstructured":"Burgermeister P, Calhoun ME, Winkler DT, Jucker M. Mechanisms of cerebrovascular amyloid deposition. Lessons from mouse models. Ann N Y Acad Sci. 2000;903:307\u201316.","journal-title":"Ann N Y Acad Sci"},{"key":"755_CR106","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1126\/science.1194516","volume":"330","author":"YS Eisele","year":"2010","unstructured":"Eisele YS, Oberm\u00fcller U, Heilbronner G, Baumann F, Kaeser SA, Wolburg H, et al. Peripherally applied Abeta-containing inoculates induce cerebral beta-amyloidosis. Science. 2010;330:980\u20132.","journal-title":"Science."},{"key":"755_CR107","doi-asserted-by":"publisher","first-page":"4778","DOI":"10.2741\/3567","volume":"14","author":"S Love","year":"2009","unstructured":"Love S, Miners S, Palmer J, Chalmers K, Kehoe P. Insights into the pathogenesis and pathogenicity of cerebral amyloid angiopathy. Front Biosci (Landmark Ed). 2009;14:4778\u201392.","journal-title":"Front Biosci (Landmark Ed)"},{"key":"755_CR108","doi-asserted-by":"publisher","first-page":"16666","DOI":"10.1021\/jacs.7b08089","volume":"139","author":"W Zheng","year":"2017","unstructured":"Zheng W, Tsai MY, Wolynes PG. Comparing the aggregation free energy landscapes of amyloid beta(1-42) and amyloid beta(1-40). J Am Chem Soc. 2017;139:16666\u201376.","journal-title":"J Am Chem Soc"},{"key":"755_CR109","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/1479-5876-11-107","volume":"11","author":"L Yang","year":"2013","unstructured":"Yang L, Kress BT, Weber HJ, Thiyagarajan M, Wang B, Deane R, et al. Evaluating glymphatic pathway function utilizing clinically relevant intrathecal infusion of CSF tracer. J Transl Med. 2013;11:107.","journal-title":"J Transl Med"},{"key":"755_CR110","doi-asserted-by":"publisher","first-page":"E881","DOI":"10.1073\/pnas.1416065112","volume":"112","author":"BH Han","year":"2015","unstructured":"Han BH, Zhou ML, Johnson AW, Singh I, Liao F, Vellimana AK, et al. Contribution of reactive oxygen species to cerebral amyloid angiopathy, vasomotor dysfunction, and microhemorrhage in aged Tg2576 mice. Proc Natl Acad Sci U S A. 2015;112:E881\u201390.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"755_CR111","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1097\/00005072-198601000-00007","volume":"45","author":"TI Mandybur","year":"1986","unstructured":"Mandybur TI. Cerebral amyloid angiopathy: the vascular pathology and complications. J Neuropathol Exp Neurol. 1986;45:79\u201390.","journal-title":"J Neuropathol Exp Neurol"},{"key":"755_CR112","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1002\/ana.410300503","volume":"30","author":"JP Vonsattel","year":"1991","unstructured":"Vonsattel JP, Myers RH, Hedley-Whyte ET, Ropper AH, Bird ED, Richardson EP. Cerebral amyloid angiopathy without and with cerebral hemorrhages: a comparative histological study. Ann Neurol. 1991;30:637\u201349.","journal-title":"Ann Neurol"},{"key":"755_CR113","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1093\/jnen\/62.9.885","volume":"62","author":"T Revesz","year":"2003","unstructured":"Revesz T, Ghiso J, Lashley T, Plant G, Rostagno A, Frangione B, et al. Cerebral amyloid angiopathies: a pathologic, biochemical, and genetic view. J Neuropathol Exp Neurol. 2003;62:885\u201398.","journal-title":"J Neuropathol Exp Neurol"},{"key":"755_CR114","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1159\/000105156","volume":"4","author":"B Van Broeck","year":"2007","unstructured":"Van Broeck B, Van Broeckhoven C, Kumar-Singh S. Current insights into molecular mechanisms of Alzheimer disease and their implications for therapeutic approaches. Neurodegener Dis. 2007;4:349\u201365.","journal-title":"Neurodegener Dis"},{"key":"755_CR115","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1161\/STROKEAHA.111.627562","volume":"43","author":"AMS Hartz","year":"2012","unstructured":"Hartz AMS, Bauer B, Soldner ELB, Wolf A, Boy S, Backhaus R, et al. Amyloid-\u03b2 contributes to blood-brain barrier leakage in transgenic human amyloid precursor protein mice and in humans with cerebral amyloid angiopathy. Stroke. 2012;43:514\u201323.","journal-title":"Stroke."},{"key":"755_CR116","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1161\/01.STR.19.2.205","volume":"19","author":"J Masuda","year":"1988","unstructured":"Masuda J, Tanaka K, Ueda K, Omae T. Autopsy study of incidence and distribution of cerebral amyloid angiopathy in Hisayama, Japan. Stroke. 1988;19:205\u201310.","journal-title":"Stroke"},{"key":"755_CR117","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1161\/01.STR.14.6.924","volume":"14","author":"HV Vinters","year":"1983","unstructured":"Vinters HV, Gilbert JJ. Cerebral amyloid angiopathy: incidence and complications in the aging brain. II. The distribution of amyloid vascular changes. Stroke. 1983;14:924\u20138.","journal-title":"Stroke."},{"key":"755_CR118","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1212\/WNL.0000000000003746","volume":"88","author":"A Charidimou","year":"2017","unstructured":"Charidimou A, Boulouis G, Pasi M, Auriel E, van Etten ES, Haley K, et al. MRI-visible perivascular spaces in cerebral amyloid angiopathy and hypertensive arteriopathy. Neurology. 2017;88:1157\u201364.","journal-title":"Neurology."},{"key":"755_CR119","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s10571-016-0343-6","volume":"36","author":"J Ramirez","year":"2016","unstructured":"Ramirez J, Berezuk C, McNeely AA, Gao F, McLaurin J, Black SE. Imaging the perivascular space as a potential biomarker of neurovascular and neurodegenerative diseases. Cell Mol Neurobiol. 2016;36:289\u201399.","journal-title":"Cell Mol Neurobiol"},{"key":"755_CR120","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s00401-011-0925-9","volume":"123","author":"Y Okamoto","year":"2012","unstructured":"Okamoto Y, Yamamoto T, Kalaria RN, Senzaki H, Maki T, Hase Y, et al. Cerebral hypoperfusion accelerates cerebral amyloid angiopathy and promotes cortical microinfarcts. Acta Neuropathol. 2012;123:381\u201394.","journal-title":"Acta Neuropathol"},{"key":"755_CR121","doi-asserted-by":"publisher","first-page":"3697","DOI":"10.1093\/brain\/awr300","volume":"134","author":"M Garcia-Alloza","year":"2011","unstructured":"Garcia-Alloza M, Gregory J, Kuchibhotla KV, Fine S, Wei Y, Ayata C, et al. Cerebrovascular lesions induce transient \u03b2-amyloid deposition. Brain. 2011;134:3697\u2013707.","journal-title":"Brain."},{"key":"755_CR122","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/j.jalz.2017.02.010","volume":"13","author":"JO Cerasuolo","year":"2017","unstructured":"Cerasuolo JO, Cipriano LE, Sposato LA, Kapral MK, Fang J, Gill SS, et al. Population-based stroke and dementia incidence trends: age and sex variations. Alzheimers Dement. 2017;13:1081\u20138.","journal-title":"Alzheimers Dement"},{"key":"755_CR123","doi-asserted-by":"publisher","first-page":"e41","DOI":"10.1161\/STROKEAHA.109.559880","volume":"41","author":"GM Savva","year":"2010","unstructured":"Savva GM, Stephan BCM, Alzheimer\u2019s Society Vascular Dementia Systematic Review Group. Epidemiological studies of the effect of stroke on incident dementia: a systematic review. Stroke. 2010;41:e41\u20136.","journal-title":"Stroke."},{"key":"755_CR124","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/S1474-4422(09)70236-4","volume":"8","author":"ST Pendlebury","year":"2009","unstructured":"Pendlebury ST, Rothwell PM. Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis. Lancet Neurol. 2009;8:1006\u201318.","journal-title":"Lancet Neurol"},{"key":"755_CR125","doi-asserted-by":"publisher","first-page":"7216","DOI":"10.4081\/ni.2017.7216","volume":"9","author":"J Surawan","year":"2017","unstructured":"Surawan J, Areemit S, Tiamkao S, Sirithanawuthichai T, Saensak S. Risk factors associated with post-stroke dementia: a systematic review and meta-analysis. Neurol Int. 2017;9:7216.","journal-title":"Neurol Int"},{"key":"755_CR126","doi-asserted-by":"publisher","first-page":"3064","DOI":"10.1161\/STROKEAHA.114.006078","volume":"45","author":"E Milner","year":"2014","unstructured":"Milner E, Zhou ML, Johnson AW, Vellimana AK, Greenberg JK, Holtzman DM, et al. Cerebral amyloid angiopathy increases susceptibility to infarction after focal cerebral ischemia in Tg2576 mice. Stroke. 2014;45:3064\u20139.","journal-title":"Stroke."},{"key":"755_CR127","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.brainresrev.2003.08.001","volume":"43","author":"AAM Rensink","year":"2003","unstructured":"Rensink AAM, de Waal RMW, Kremer B, Verbeek MM. Pathogenesis of cerebral amyloid angiopathy. Brain Res Brain Res Rev. 2003;43:207\u201323.","journal-title":"Brain Res Brain Res Rev"},{"key":"755_CR128","doi-asserted-by":"publisher","first-page":"3323","DOI":"10.1161\/STROKEAHA.110.608257","volume":"42","author":"Y Yang","year":"2011","unstructured":"Yang Y, Rosenberg GA. Blood\u2013brain barrier breakdown in acute and chronic cerebrovascular disease. Stroke. 2011;42:3323\u20138.","journal-title":"Stroke."},{"key":"755_CR129","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.neuron.2008.01.003","volume":"57","author":"BV Zlokovic","year":"2008","unstructured":"Zlokovic BV. The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron. 2008;57:178\u2013201.","journal-title":"Neuron."},{"key":"755_CR130","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.nbd.2016.07.013","volume":"95","author":"A Ashok","year":"2016","unstructured":"Ashok A, Rai NK, Raza W, Pandey R, Bandyopadhyay S. Chronic cerebral hypoperfusion-induced impairment of A\u03b2 clearance requires HB-EGF-dependent sequential activation of HIF1\u03b1 and MMP9. Neurobiol Dis. 2016;95:179\u201393.","journal-title":"Neurobiol Dis"},{"key":"755_CR131","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.tins.2005.02.001","volume":"28","author":"BV Zlokovic","year":"2005","unstructured":"Zlokovic BV. Neurovascular mechanisms of Alzheimer\u2019s neurodegeneration. Trends Neurosci. 2005;28:202\u20138.","journal-title":"Trends Neurosci"},{"key":"755_CR132","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1212\/01.wnl.0000260066.98681.2e","volume":"68","author":"C Kinnecom","year":"2007","unstructured":"Kinnecom C, Lev MH, Wendell L, Smith EE, Rosand J, Frosch MP, et al. Course of cerebral amyloid angiopathy-related inflammation. Neurology. 2007;68:1411\u20136.","journal-title":"Neurology."},{"key":"755_CR133","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/nrn.2017.48","volume":"18","author":"K Kisler","year":"2017","unstructured":"Kisler K, Nelson AR, Montagne A, Zlokovic BV. Cerebral blood flow regulation and neurovascular dysfunction in Alzheimer disease. Nat Rev Neurosci. 2017;18:419\u201334.","journal-title":"Nat Rev Neurosci"},{"key":"755_CR134","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1126\/science.1123511","volume":"312","author":"S Boill\u00e9e","year":"2006","unstructured":"Boill\u00e9e S, Yamanaka K, Lobsiger CS, Copeland NG, Jenkins NA, Kassiotis G, et al. Onset and progression in inherited ALS determined by motor neurons and microglia. Science. 2006;312:1389\u201392.","journal-title":"Science."},{"key":"755_CR135","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1007\/s11064-007-9342-9","volume":"32","author":"J Lok","year":"2007","unstructured":"Lok J, Gupta P, Guo S, Kim WJ, Whalen MJ, van Leyen K, et al. Cell-cell signaling in the neurovascular unit. Neurochem Res. 2007;32:2032\u201345.","journal-title":"Neurochem Res"},{"key":"755_CR136","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1111\/j.1750-3639.2007.00067.x","volume":"17","author":"S Man","year":"2007","unstructured":"Man S, Ubogu EE, Ransohoff RM. Inflammatory cell migration into the central nervous system: a few new twists on an old tale. Brain Pathol. 2007;17:243\u201350.","journal-title":"Brain Pathol"},{"key":"755_CR137","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.neurobiolaging.2017.03.021","volume":"55","author":"Z Yin","year":"2017","unstructured":"Yin Z, Raj D, Saiepour N, Van Dam D, Brouwer N, Holtman IR, et al. Immune hyperreactivity of A\u03b2 plaque-associated microglia in Alzheimer\u2019s disease. Neurobiol Aging. 2017;55:115\u201322.","journal-title":"Neurobiol Aging"},{"key":"755_CR138","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.nbd.2009.07.030","volume":"37","author":"NJ Abbott","year":"2010","unstructured":"Abbott NJ, Patabendige AAK, Dolman DEM, Yusof SR, Begley DJ. Structure and function of the blood-brain barrier. Neurobiol Dis. 2010;37:13\u201325.","journal-title":"Neurobiol Dis"},{"key":"755_CR139","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12987-018-0113-6","volume":"15","author":"SB Hladky","year":"2018","unstructured":"Hladky SB, Barrand MA. Elimination of substances from the brain parenchyma: efflux via perivascular pathways and via the blood-brain barrier. Fluids Barriers CNS. 2018;15:30.","journal-title":"Fluids Barriers CNS"},{"key":"755_CR140","doi-asserted-by":"publisher","first-page":"283","DOI":"10.2174\/1567205014666170417111859","volume":"15","author":"Y Gao","year":"2018","unstructured":"Gao Y, Tan L, Yu JT, Tan L. Tau in Alzheimer\u2019s disease: mechanisms and therapeutic strategies. Curr Alzheimer Res. 2018;15:283\u2013300.","journal-title":"Curr Alzheimer Res"},{"key":"755_CR141","first-page":"CD001928","volume":"2","author":"J Zhang","year":"2019","unstructured":"Zhang J, Liu J, Li D, Zhang C, Liu M. Calcium antagonists for acute ischemic stroke. Cochrane Database Syst Rev. 2019;2:CD001928.","journal-title":"Cochrane Database Syst Rev"},{"key":"755_CR142","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.2967\/jnumed.116.187211","volume":"58","author":"MJ de Leon","year":"2017","unstructured":"de Leon MJ, Li Y, Okamura N, Tsui WH, Saint Louis LA, Glodzik L, et al. CSF clearance in Alzheimer disease measured with dynamic PET. J Nucl Med. 2017;58:1471\u20136.","journal-title":"J Nucl Med"},{"key":"755_CR143","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1002\/mrm.26779","volume":"79","author":"H Lee","year":"2018","unstructured":"Lee H, Mortensen K, Sanggaard S, Koch P, Brunner H, Quistorff B, et al. Quantitative Gd-DOTA uptake from cerebrospinal fluid into rat brain using 3D VFA-SPGR at 9.4T. Magn Reson Med. 2018;79:1568\u201378.","journal-title":"Magn Reson Med"},{"key":"755_CR144","doi-asserted-by":"publisher","first-page":"e52664","DOI":"10.1371\/journal.pone.0052664","volume":"7","author":"D Fleischman","year":"2012","unstructured":"Fleischman D, Berdahl JP, Zaydlarova J, Stinnett S, Fautsch MP, Allingham RR. Cerebrospinal fluid pressure decreases with older age. PLoS One. 2012;7:e52664.","journal-title":"PLoS One"},{"key":"755_CR145","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1212\/WNL.57.10.1763","volume":"57","author":"GD Silverberg","year":"2001","unstructured":"Silverberg GD, Heit G, Huhn S, Jaffe RA, Chang SD, Bronte-Stewart H, et al. The cerebrospinal fluid production rate is reduced in dementia of the Alzheimer\u2019s type. Neurology. 2001;57:1763\u20136.","journal-title":"Neurology."},{"key":"755_CR146","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1110\/ps.041266605","volume":"14","author":"P Hortschansky","year":"2005","unstructured":"Hortschansky P, Schroeckh V, Christopeit T, Zandomeneghi G, F\u00e4ndrich M. The aggregation kinetics of Alzheimer\u2019s beta-amyloid peptide is controlled by stochastic nucleation. Protein Sci. 2005;14:1753\u20139.","journal-title":"Protein Sci"},{"key":"755_CR147","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.exger.2012.05.023","volume":"47","author":"DR Thal","year":"2012","unstructured":"Thal DR, Grinberg LT, Attems J. Vascular dementia: different forms of vessel disorders contribute to the development of dementia in the elderly brain. Exp Gerontol. 2012;47:816\u201324.","journal-title":"Exp Gerontol"},{"key":"755_CR148","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1212\/WNL.0000000000002169","volume":"85","author":"B Wu","year":"2015","unstructured":"Wu B, Yao X, Lei C, Liu M, Selim MH. Enlarged perivascular spaces and small diffusion-weighted lesions in intracerebral hemorrhage. Neurology. 2015;85:2045\u201352.","journal-title":"Neurology."},{"key":"755_CR149","doi-asserted-by":"publisher","first-page":"e2160","DOI":"10.1038\/cddis.2016.63","volume":"7","author":"C Luo","year":"2016","unstructured":"Luo C, Yao X, Li J, He B, Liu Q, Ren H, et al. Paravascular pathways contribute to vasculitis and neuroinflammation after subarachnoid hemorrhage independently of glymphatic control. Cell Death Dis. 2016;7:e2160.","journal-title":"Cell Death Dis"},{"key":"755_CR150","first-page":"62","volume":"23","author":"AA Rabinstein","year":"2017","unstructured":"Rabinstein AA. Treatment of acute ischemic stroke. Continuum (Minneap Minn). 2017;23:62\u201381.","journal-title":"Continuum (Minneap Minn)"},{"key":"755_CR151","doi-asserted-by":"publisher","first-page":"3006","DOI":"10.1161\/STROKEAHA.117.019081","volume":"48","author":"Y Pan","year":"2017","unstructured":"Pan Y, Cai X, Jing J, Meng X, Li H, Wang Y, et al. Stress hyperglycemia and prognosis of minor ischemic stroke and transient ischemic attack: the CHANCE study (clopidogrel in high-risk patients with acute nondisabling cerebrovascular events). Stroke. 2017;48:3006\u201311.","journal-title":"Stroke."},{"key":"755_CR152","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.mehy.2017.08.017","volume":"107","author":"R Reshi","year":"2017","unstructured":"Reshi R, Streib C, Ezzeddine M, Biros M, Miller B, Lakshminarayan K, et al. Hyperglycemia in acute ischemic stroke: is it time to re-evaluate our understanding? Med Hypotheses. 2017;107:78\u201380.","journal-title":"Med Hypotheses"},{"key":"755_CR153","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/S1474-4422(09)70051-1","volume":"8","author":"HM den Hertog","year":"2009","unstructured":"den Hertog HM, van der Worp HB, van Gemert HMA, Algra A, Kappelle LJ, van Gijn J, et al. The Paracetamol (Acetaminophen) In Stroke (PAIS) trial: a multicentre, randomised, placebo-controlled, phase III trial. Lancet Neurol. 2009;8:434\u201340.","journal-title":"Lancet Neurol"},{"key":"755_CR154","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1161\/STROKEAHA.114.005179","volume":"45","author":"L Park","year":"2014","unstructured":"Park L, Koizumi K, El Jamal S, Zhou P, Previti ML, Van Nostrand WE, et al. Age-dependent neurovascular dysfunction and damage in a mouse model of cerebral amyloid angiopathy. Stroke. 2014;45:1815\u201321.","journal-title":"Stroke."},{"issue":"317","key":"755_CR155","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.neuroscience.2016.01.003","volume":"11","author":"H Sun","year":"2016","unstructured":"Sun H, Liang R, Wang B, Zhou Y, Liu M, Fang F, et al. Aquaporin-4 mediates communication between astrocyte and microglia: implications of neuroinflammation in experimental Parkinson's disease. Neuroscience. 2016;11(317):65\u201375.","journal-title":"Neuroscience."},{"key":"755_CR156","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1096\/fj.201600896","volume":"31","author":"H Ren","year":"2017","unstructured":"Ren H, Luo C, Feng Y, Yao X, Shi Z, Liang F, et al. Omega-3 polyunsaturated fatty acids promote amyloid-\u03b2 clearance from the brain through mediating the function of the glymphatic system. FASEB J. 2017;31:282\u201393.","journal-title":"FASEB J"},{"key":"755_CR157","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.jns.2017.01.072","volume":"375","author":"Q Chen","year":"2017","unstructured":"Chen Q, Feng Z, Tan Q, Guo J, Tang J, Tan L, et al. Post-hemorrhagic hydrocephalus: recent advances and new therapeutic insights. J Neurol Sci. 2017;375:220\u201330.","journal-title":"J Neurol Sci"},{"key":"755_CR158","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.trsl.2016.08.004","volume":"180","author":"Z Feng","year":"2017","unstructured":"Feng Z, Tan Q, Tang J, Li L, Tao Y, Chen Y, et al. Intraventricular administration of urokinase as a novel therapeutic approach for communicating hydrocephalus. Transl Res. 2017;180:77\u201390 e2.","journal-title":"Transl Res"},{"key":"755_CR159","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1212\/01.wnl.0000316197.04157.6f","volume":"71","author":"GD Silverberg","year":"2008","unstructured":"Silverberg GD, Mayo M, Saul T, Fellmann J, Carvalho J, McGuire D. Continuous CSF drainage in AD: results of a double-blind, randomized, placebo-controlled study. Neurology. 2008;71:202\u20139.","journal-title":"Neurology."},{"key":"755_CR160","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1097\/01.jnen.0000240466.10758.ce","volume":"65","author":"JAR Nicoll","year":"2006","unstructured":"Nicoll JAR, Barton E, Boche D, Neal JW, Ferrer I, Thompson P, et al. Abeta species removal after abeta42 immunization. J Neuropathol Exp Neurol. 2006;65:1040\u20138.","journal-title":"J Neuropathol Exp Neurol"},{"key":"755_CR161","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1742-2094-1-24","volume":"1","author":"DM Wilcock","year":"2004","unstructured":"Wilcock DM, Rojiani A, Rosenthal A, Subbarao S, Freeman MJ, Gordon MN, et al. Passive immunotherapy against Abeta in aged APP-transgenic mice reverses cognitive deficits and depletes parenchymal amyloid deposits in spite of increased vascular amyloid and microhemorrhage. J Neuroinflammation. 2004;1:24.","journal-title":"J Neuroinflammation"},{"key":"755_CR162","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.neuint.2017.03.011","volume":"107","author":"M Peters","year":"2017","unstructured":"Peters M, Wielsch B, Boltze J. The role of SUMOylation in cerebral hypoxia and ischemia. Neurochem Int. 2017;107:66\u201377.","journal-title":"Neurochem Int"},{"key":"755_CR163","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1038\/nm783","volume":"8","author":"C Hock","year":"2002","unstructured":"Hock C, Konietzko U, Papassotiropoulos A, Wollmer A, Streffer J, von Rotz RC, et al. Generation of antibodies specific for beta-amyloid by vaccination of patients with Alzheimer disease. Nat Med. 2002;8:1270\u20135.","journal-title":"Nat Med"},{"key":"755_CR164","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/S0896-6273(03)00294-0","volume":"38","author":"C Hock","year":"2003","unstructured":"Hock C, Konietzko U, Streffer JR, Tracy J, Signorell A, M\u00fcller-Tillmanns B, et al. Antibodies against beta-amyloid slow cognitive decline in Alzheimer\u2019s disease. Neuron. 2003;38:547\u201354.","journal-title":"Neuron."},{"key":"755_CR165","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/nm840","volume":"9","author":"JAR Nicoll","year":"2003","unstructured":"Nicoll JAR, Wilkinson D, Holmes C, Steart P, Markham H, Weller RO. Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report. Nat Med. 2003;9:448\u201352.","journal-title":"Nat Med"},{"key":"755_CR166","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1161\/CIRCRESAHA.117.311054","volume":"121","author":"L Park","year":"2017","unstructured":"Park L, Uekawa K, Garcia-Bonilla L, Koizumi K, Murphy M, Pitstick R, et al. Brain perivascular macrophages initiate the neurovascular dysfunction of Alzheimer A\u03b2 peptides. Circ Res. 2017;121:258\u201369.","journal-title":"Circ Res"},{"key":"755_CR167","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1073\/pnas.0805453106","volume":"106","author":"CA Hawkes","year":"2009","unstructured":"Hawkes CA, McLaurin J. Selective targeting of perivascular macrophages for clearance of beta-amyloid in cerebral amyloid angiopathy. Proc Natl Acad Sci U S A. 2009;106:1261\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"755_CR168","doi-asserted-by":"publisher","first-page":"126138","DOI":"10.1172\/jci.insight.126138","volume":"3","author":"BA Plog","year":"2018","unstructured":"Plog BA, Mestre H, Olveda GE, Sweeney AM, Kenney HM, Cove A, et al. Transcranial optical imaging reveals a pathway for optimizing the delivery of immunotherapeutics to the brain. JCI Insight. 2018;3:126138.","journal-title":"JCI Insight"},{"key":"755_CR169","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1586\/14737175.2015.955853","volume":"15","author":"F Di Domenico","year":"2015","unstructured":"Di Domenico F, Barone E, Perluigi M, Butterfield DA. Strategy to reduce free radical species in Alzheimer\u2019s disease: an update of selected antioxidants. Expert Rev Neurother. 2015;15:19\u201340.","journal-title":"Expert Rev Neurother"},{"key":"755_CR170","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/s12883-017-0945-8","volume":"17","author":"A De Vos","year":"2017","unstructured":"De Vos A, Bjerke M, Brouns R, De Roeck N, Jacobs D, Van den Abbeele L, et al. Neurogranin and tau in cerebrospinal fluid and plasma of patients with acute ischemic stroke. BMC Neurol. 2017;17:170.","journal-title":"BMC Neurol"},{"key":"755_CR171","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s41467-017-00618-0","volume":"8","author":"M Bi","year":"2017","unstructured":"Bi M, Gladbach A, van Eersel J, Ittner A, Przybyla M, van Hummel A, et al. Tau exacerbates excitotoxic brain damage in an animal model of stroke. Nat Commun. 2017;8:473.","journal-title":"Nat Commun"},{"key":"755_CR172","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.tips.2017.04.005","volume":"38","author":"P Poprac","year":"2017","unstructured":"Poprac P, Jomova K, Simunkova M, Kollar V, Rhodes CJ, Valko M. Targeting free radicals in oxidative stress-related human diseases. Trends Pharmacol Sci. 2017;38:592\u2013607.","journal-title":"Trends Pharmacol Sci"},{"key":"755_CR173","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.biopha.2015.12.024","volume":"78","author":"KA Wojtunik-Kulesza","year":"2016","unstructured":"Wojtunik-Kulesza KA, Oniszczuk A, Oniszczuk T, Waksmundzka-Hajnos M. The influence of common free radicals and antioxidants on development of Alzheimer\u2019s disease. Biomed Pharmacother. 2016;78:39\u201349.","journal-title":"Biomed Pharmacother"},{"key":"755_CR174","doi-asserted-by":"publisher","first-page":"3996","DOI":"10.2174\/1381612822666160520115248","volume":"22","author":"A Spinello","year":"2016","unstructured":"Spinello A, Bonsignore R, Barone G, Keppler BK, Terenzi A. Metal ions and metal complexes in Alzheimer\u2019s disease. Curr Pharm Des. 2016;22:3996\u20134010.","journal-title":"Curr Pharm Des"},{"key":"755_CR175","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejmech.2019.05.020","volume":"176","author":"P Zhang","year":"2019","unstructured":"Zhang P, Xu S, Zhu Z, Xu J. Multi-target design strategies for the improved treatment of Alzheimer\u2019s disease. Eur J Med Chem. 2019;176:228\u201347.","journal-title":"Eur J Med Chem"},{"key":"755_CR176","doi-asserted-by":"crossref","unstructured":"Sun MS, Jin H, Sun X, Huang S, Zhang FL, Guo ZN, et al. Free radical damage in ischemia-reperfusion injury: an obstacle in acute ischemic stroke after revascularization therapy. Oxidative Med Cell Longev. 2018;3804979.","DOI":"10.1155\/2018\/3804979"}],"container-title":["Translational Stroke Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12975-019-00755-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12975-019-00755-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12975-019-00755-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T20:26:19Z","timestamp":1650486379000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12975-019-00755-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,28]]},"references-count":176,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["755"],"URL":"https:\/\/doi.org\/10.1007\/s12975-019-00755-2","relation":{},"ISSN":["1868-4483","1868-601X"],"issn-type":[{"value":"1868-4483","type":"print"},{"value":"1868-601X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,28]]},"assertion":[{"value":"15 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Authors RG, LMR, EMH, and RMD declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}